Observing ARTICE® treatment in the ICU
Part of Infections clinical trials.
This study is collecting real-world data on ARTICE® treatment for adults in the ICU. It helps doctors understand how this treatment works in daily practice.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must be in the intensive care unit (ICU).
- Your doctor must plan to give you ARTICE® treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks whether information collected routinely in the ICU can help doctors recognize sepsis or septic shock earlier. If it works, it may improve how quickly diagnosis happens and potentially outcomes for patients.
This study looks at how your immune cells respond during a severe infection in the ICU. It aims to better predict how the infection will progress and help tailor treatment.
This study tracks how doctors treat septic shock in the ICU to learn what works best. If you have septic shock, joining this study helps researchers understand which treatments are most effective, and you'll get the same care you would anyway.
This trial studies how early severe illness in the ICU can be understood and tracked using health data (bioinformatics/informatics). It may help improve care decisions for people who arrive to the ICU soon after an emergency department visit.
This trial looks at how the immune system changes after septic shock in adults in the ICU. It may help doctors better predict or manage complications by studying blood markers a few days after starting treatment.
This trial studies treatments for sepsis, a serious infection complication, in ICU patients. It aims to find better ways to care for critically ill patients with sepsis.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.